Literature DB >> 21155594

Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium.

Karla L Malloy1, Francisco A Villa, Niclas Engene, Teatulohi Matainaho, Lena Gerwick, William H Gerwick.   

Abstract

A Papua New Guinea collection of the marine cyanobacterium cf. Lyngbya sordida yielded three known compounds as well as a new PKS-NRPS-derived malyngamide with anti-inflammatory and cytotoxic activity. Malyngamide 2 features an extensively oxidized cyclohexanone ring. Resolution of the ring core as a 6,8,9-triol rather then a 7,8,9-triol and relative configuration was based on chemical shift and bond geometry modeling in conjunction with homonuclear and heteronuclear coupling constants, NOE and ROE correlations, and other structural information. Malyngamide 2 exhibited anti-inflammatory activity in LPS-induced RAW macrophage cells (IC(50) = 8.0 μM) with only modest cytotoxicity to the mammalian cell line.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21155594      PMCID: PMC3227558          DOI: 10.1021/np1005407

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

1.  Malyngamides O and P from the sea hare Stylocheilus longicauda.

Authors:  W A Gallimore; P J Scheuer
Journal:  J Nat Prod       Date:  2000-10       Impact factor: 4.050

Review 2.  Nitrogen-containing metabolites from marine cyanobacteria.

Authors:  W H Gerwick; L T Tan; N Sitachitta
Journal:  Alkaloids Chem Biol       Date:  2001

3.  A new biologically active malyngamide from a New Zealand collection of the sea hare Bursatella leachii.

Authors:  David R Appleton; Mary A Sewell; Michael V Berridge; Brent R Copp
Journal:  J Nat Prod       Date:  2002-04       Impact factor: 4.050

4.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

5.  Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts.

Authors:  R L Manger; L S Leja; S Y Lee; J M Hungerford; Y Hokama; R W Dickey; H R Granade; R Lewis; T Yasumoto; M M Wekell
Journal:  J AOAC Int       Date:  1995 Mar-Apr       Impact factor: 1.913

6.  Hydroxymalonyl-acyl carrier protein (ACP) and aminomalonyl-ACP are two additional type I polyketide synthase extender units.

Authors:  Yolande A Chan; Michael T Boyne; Angela M Podevels; Amy K Klimowicz; Jo Handelsman; Neil L Kelleher; Michael G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Malyngamides M and N from the Hawaiian Red Alga Gracilaria coronopifolia

Authors: 
Journal:  J Nat Prod       Date:  1998-01-23       Impact factor: 4.050

8.  Selective MyD88-dependent pathway inhibition by the cyanobacterial natural product malyngamide F acetate.

Authors:  Francisco A Villa; Kelly Lieske; Lena Gerwick
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

9.  Malyngamide X: the first (7R)-lyngbic acid that connects to a new tripeptide backbone from the Thai sea hare Bursatella leachii.

Authors:  Suchada Suntornchashwej; Khanit Suwanborirux; Kazushi Koga; Minoru Isobe
Journal:  Chem Asian J       Date:  2007-01-08

10.  Wewakazole, a novel cyclic dodecapeptide from a Papua New Guinea Lyngbya majuscula.

Authors:  Lisa M Nogle; Brian L Marquez; William H Gerwick
Journal:  Org Lett       Date:  2003-01-09       Impact factor: 6.005

View more
  13 in total

Review 1.  Biologically active secondary metabolites from marine cyanobacteria.

Authors:  Joshawna K Nunnery; Emily Mevers; William H Gerwick
Journal:  Curr Opin Biotechnol       Date:  2010-10-26       Impact factor: 9.740

2.  Marine cyanobacterial fatty acid amides acting on cannabinoid receptors.

Authors:  Rana Montaser; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2012-11-09       Impact factor: 3.164

3.  Ketoreductase Domain Dysfunction Expands Chemodiversity: Malyngamide Biosynthesis in the Cyanobacterium Okeania hirsuta.

Authors:  Nathan A Moss; Tiago Leão; Michael R Rankin; Tyler M McCullough; Pingping Qu; Anton Korobeynikov; Janet L Smith; Lena Gerwick; William H Gerwick
Journal:  ACS Chem Biol       Date:  2018-12-03       Impact factor: 5.100

Review 4.  Anti-lung cancer properties of cyanobacterial bioactive compounds.

Authors:  Mirza S Baig; Sajjan Rajpoot; Tomokazu Ohishi; Rajkumar Savai; Sascha Seidel; Nina A Kamennaya; Evgeny E Bezsonov; Alexander N Orekhov; Pratik Mahajan; Kundan Solanki; Uzma Saqib
Journal:  Arch Microbiol       Date:  2022-09-05       Impact factor: 2.667

Review 5.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

Review 6.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

7.  Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.

Authors:  Margarida Costa; Mónica Garcia; João Costa-Rodrigues; Maria Sofia Costa; Maria João Ribeiro; Maria Helena Fernandes; Piedade Barros; Aldo Barreiro; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2013-12-31       Impact factor: 5.118

Review 8.  Uncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects.

Authors:  Rachana Singh; Parul Parihar; Madhulika Singh; Andrzej Bajguz; Jitendra Kumar; Samiksha Singh; Vijay P Singh; Sheo M Prasad
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

Review 9.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

Review 10.  Cannabinomimetric Lipids: From Natural Extract to Artificial Synthesis.

Authors:  Ya-Ru Gao; Yong-Qiang Wang
Journal:  Nat Prod Bioprospect       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.